Remove BioTech Remove Course Remove Digital Health Remove Life Science
article thumbnail

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Digital Health Global

This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital ), propels Eligo towards becoming a clinical-stage biotech. Concurrent with this financing, Laia Crespo, Ph.D., Partner at Sanofi Ventures.